Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

Clinical trial NCT05905328 · RECRUITING

Trial details

NCT number: NCT05905328
Sponsor: CytoAgents, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cytokine Release Syndrome

Start date: 2023-12-28
Primary completion: 2027-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.